Pacla Medical

Pacla Medical is a Scotland-based, private health care technology company whose novel physiotherapy device (Backhug) aims to treat pain by releasing joint stiffness in the back. Backhug allows home treatment without needing a professional practitioner and can be used to benefit patients with chronic back pain, multiple sclerosis and other conditions.

More Pacla Medical content >

Investment summary

Pacla Medical is a private health care technology firm that has developed Backhug, a robotic physiotherapy device for treating pain. Pacla operates a scalable subscription model where customers typically pay £99/month for a 12-month contract (there is also a purchase option), potentially generating high levels of SaaS-type recurring revenue. The addressable market to reduce back pain is estimated at about 197 million people globally and worth $76bn in annual revenues. Pacla’s sales for the last 12 months were £21k; it has already sold 25 units and has a waiting list for 300. The planned £5m capital raise would allow expansion into the key US market and facilitate targeted growth to c 5k units over the next 18 months, with Pacla expecting FY24 sales to reach £14.1m.

Content on Pacla Medical
Pacla Medical – executive interview
Healthcare | Edison TV | 29 June 2022
Pacla Medical – Backhug: Treating spinal joint stiffness
Healthcare | research QuickView | 24 June 2022
View more
Register to receive research on Pacla Medical as it is published